Advocates have claimed that CVS’s refusal to cover Yeztugo violates the Affordable Care Act (ACA), which requires insurers to ...

CVS Health will not cover Gilead's Yeztugo, generic name lenacapavir (LEN), citing "clinical, financial, and regulatory ...

CVS Health (NYSE:CVS), one of the leading health insurers in the U.S. and owner of the Pharmacy Benefit Manager Caremark, ...

CVS Health , which runs the largest U.S. pharmacy benefit manager, will not add Gilead Sciences' new HIV prevention drug to ...

In 2014, Caremark was accused of manipulating how drug costs were reported, prompting Aetna and SilverScript to submit false ...

Primary care physicians and the state Senate’s health care point person are questioning a proposed partnership between Mass ...

CVS Health is not entitled to coverage from insurers, including AIG and Chubb , against thousands of lawsuits over its role ...

The owner of the U.S.' largest pharmacy benefit manager is declining to cover Gilead Sciences’ long-acting HIV prevention ...

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research ...

Super investors like Buffett and Michael Bury piled heavily into UnitedHealthcare in Q2, signalling confidence that the ...

CVS Health reported second quarter GAAP diluted EPS of 80 cents decreased from $1.41 in the prior year, reflecting the impact of two litigation charges associated with the company’s past ...